Saklani-Jusforgues Hélène, Fontan Elisabeth, Soussi Neirouz, Milon Geneviève, Goossens Pierre L
Unité d'Immunophysiologie et Parasitisme Intracellulaire, Institut Pasteur, Paris, France.
Infect Immun. 2003 Mar;71(3):1083-90. doi: 10.1128/IAI.71.3.1083-1090.2003.
Listeria monocytogenes is considered as a potential live bacterial vector, particularly for the induction of CD8 T cells. The CD4 T-cell immune response triggered after enteral immunization of mice has not yet been thoroughly characterized. The dynamics of gamma interferon (IFN-gamma)- and interleukin-4 (IL-4)-secreting CD4 T cells were analyzed after priming through intragastric delivery of an attenuated delta actA recombinant L. monocytogenes strain expressing the Leishmania major LACK protein; a peptide of this protein, LACK(158-173) peptide (pLACK), is a well-characterized CD4 T-cell target in BALB/c mice. Five compartments were monitored: Peyer's patches, mesenteric lymph nodes (MLN), spleen, liver, and blood. A single intragastric inoculation of delta actA-LACK-LM in BALB/c mice led to colonization of the MLN and spleen at a significant level for at least 3 days. Efficient priming of IFN-gamma-secreting pLACK-reactive CD4 T cells was observed in all tested compartments. Interestingly, IL-4-secreting pLACK-reactive CD4 T cells were detectable at day 6 or 7 only in blood and liver. The absence of translocation of viable bacteria through the intestinal epithelium after further delta actA-LACK-LM inoculations was concomitant with the absence of an increase in the level of IFN-gamma secreted by the MLN, blood, and splenic pLACK-reactive Th1 T cells, although the levels remained significantly above the basal level. No change in this population size was detected in the spleen. However, an increase in the number of intragastric inoculations had a clinical beneficial effect in L. major-infected BALB/c mice. L. monocytogenes thus presents the potential of an efficient vector for induction of CD4 T cells when administered by the enteral route.
单核细胞增生李斯特菌被认为是一种潜在的活细菌载体,特别是用于诱导CD8 T细胞。小鼠经肠道免疫后引发的CD4 T细胞免疫反应尚未得到充分表征。通过胃内递送表达利什曼原虫主要LACK蛋白的减毒ΔactA重组单核细胞增生李斯特菌菌株进行初次免疫后,分析了分泌γ干扰素(IFN-γ)和白细胞介素-4(IL-4)的CD4 T细胞的动态变化;该蛋白的一种肽,LACK(158 - 173)肽(pLACK),是BALB/c小鼠中一个特征明确的CD4 T细胞靶点。监测了五个部位:派伊尔结、肠系膜淋巴结(MLN)、脾脏、肝脏和血液。在BALB/c小鼠中单次胃内接种ΔactA-LACK-LM导致MLN和脾脏在至少3天内有显著水平的定植。在所有测试部位均观察到分泌IFN-γ的pLACK反应性CD4 T细胞的有效初次免疫。有趣的是,分泌IL-4的pLACK反应性CD4 T细胞仅在第6天或第7天在血液和肝脏中可检测到。在进一步接种ΔactA-LACK-LM后,活细菌未通过肠上皮细胞发生易位,这与MLN、血液和脾脏中pLACK反应性Th1 T细胞分泌的IFN-γ水平没有增加相伴,尽管该水平仍显著高于基础水平。在脾脏中未检测到该群体大小的变化。然而,增加胃内接种次数对感染利什曼原虫的BALB/c小鼠有临床有益作用。因此,当通过肠道途径给药时,单核细胞增生李斯特菌具有作为诱导CD4 T细胞的有效载体的潜力。